Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease

Author： Willy Haukeland John   Konopski Zbigniew   Linnestad Paul   Azimy Shafiullah   Marit Løberg Else   Haaland Terese   Birkeland Kåre   Bjøro Kristian  

Publisher： Informa Healthcare

ISSN： 0036-5521

Source： Scandinavian Journal of Gastroenterology, Vol.40, Iss.12, 2005-12, pp. : 1469-1477

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Surgical Treatment of Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease

By  

Digestive Diseases, Vol. 28, Iss. 1, 2010-05 ,pp. : 274-279

Karger

Access to resources Recommend Favorite

PTEN in Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis and Cancer

By  

Digestive Diseases, Vol. 28, Iss. 1, 2010-05 ,pp. : 236-246

Karger

Access to resources Recommend Favorite

Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis

By  

Current Vascular Pharmacology, Vol. 16, Iss. 3, 2018-03 ,pp. : 239-245

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality

By  

Current Vascular Pharmacology, Vol. 16, Iss. 3, 2018-03 ,pp. : 206-208

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin-related biomarkers and their relationship with hepatic fibrosis risk in patients with psoriasis, metabolic syndrome and non-alcoholic fatty liver disease

By Kawada Tomoyuki  

Journal of Gastroenterology, Vol. 48, Iss. 5, 2013-05 ,pp. : 671-672

Springer Publishing Company

Access to resources Recommend Favorite